IP Library Granted Patent US 9,115,373
Granted Patent B2
US 9,115,373 · App. 12/679,144 · Granted Aug 25, 2015

Use of AAV replication machinery for improved protein production

Inventors: Wilhelmus Theodorus Johannes Maria Christiaan Hermens (Almere, NL); Yvet Noordman (Utrecht, NL); Andrew Christian Bakker (Almere, NL)
Assignee: UNIQURE IP B.V.
C12N15/86A01K2217/05C12N2710/14143C12N2830/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,115,373
App. No.
12/679,144
Granted
Aug 25, 2015
Kind
B2
Abstract

The present invention provides a method for enhanced production of a gene product of interest in a cell, using the AAV replication machinery. The present invention further relates to a cell for use in the method of the invention and a non-human transgenic animal or a transgenic plant comprising a cell of the invention.

Claims (17)

1. An insect cell that comprises:

(a) a first expression cassette comprising:

(i) a nucleotide sequence encoding a polypeptide of interest;

(ii) a promoter operably linked to said coding nucleotide sequence that is capable of driving expression of the polypeptide of interest in the insect cell; and

(iii) a parvoviral inverted terminal repeat (ITR) nucleotide sequence flanking said expression cassette on both sides;

and

(b) a second expression cassette that comprises:

(i) a nucleotide sequence encoding at least one parvoviral Rep protein; and

(ii) a promoter operably linked to said nucleotide sequence encoding said Rep protein that is capable of driving expression of the Rep protein in the insect cell;

which insect cell does not comprise a parvoviral Cap protein or a nucleotide sequence encoding a parvoviral Cap protein, and

wherein the expression of the polypeptide of interest is increased, as compared to an insect cell which comprises said nucleotide encoding said polypeptide of interest and said promoter operably linked thereto and said flanking parvoviral ITR sequence but differs in that it does not comprise said nucleotide sequence encoding said at least one parvoviral Rep protein operably linked to said promoter capable of driving expression of the Rep protein in said cell.

2. A method for producing a polypeptide of interest in an insect cell, comprising culturing the insect cell according to claim 1 under conditions that are conducive for expression of the first and the second expression cassettes, thereby attaining said increased expression and production of said polypeptide of interest.

3. The method according to claim 2 further comprising recovering said polypeptide of interest from the culture.

4. The method according to claim 2 , wherein the second expression cassette comprises an open reading frame comprising nucleotide sequences encoding Rep78 and/or Rep68 proteins.

5. The method according to claim 2 , wherein the first and the second expression cassettes are present in a single construct that is flanked by a parvoviral ITR sequence on each side.

6. The method according to claim 2 , wherein the parvoviral ITR sequence and parvoviral Rep protein are from an adeno-associated virus.

7. The method according to claim 2 , wherein at least one of the expression cassettes is comprised in a baculoviral vector.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2014
From: HERMENS, WILHELMUS THEODORUS JOHANNES MARIA CHRISTIAAN; NOORDMAN, YVET; BAKKER, ANDREW CHRISTIAN
To: AMSTERDAM MOLECULAR THERAPEUTICS (AMT) IP B.V.
Reel/Frame 032146/0955 →
CHANGE OF NAME Recorded Feb 5, 2014
From: AMSTERDAM MOLECULAR THERAPEUTICS (AMT) IP B.V.
To: UNIQURE IP B.V.
Reel/Frame 032146/0991 →
Priority Claims (1)
EP 07075817 · Sep 19, 2007 · regional
Continuity (2)
Provisional Application 60973517 · Sep 19, 2007
Related Publication 20110119777A1 · May 19, 2011